 |
|
Identification of Plasma Biomarkers in Drug-Naïve Schizophrenia Using Targeted Metabolomics
Qiao Su, Fuyou Bi, Shu Yang, Huiming Yan, Xiaoxiao Sun, Jiayue Wang, Yuying Qiu, Meijuan Li, Shen Li, Jie Li
Psychiatry Investig. 2023;20(9):818-825. Published online 2023 Sep 19 DOI: https://doi.org/10.30773/pi.2023.0121
|
|
Peripheral Lipid Signatures, Metabolic Dysfunction, and Pathophysiology in Schizophrenia Spectrum Disorders
Sally Wu, Kristoffer J. Panganiban, Jiwon Lee, Dan Li, Emily C.C. Smith, Kateryna Maksyutynska, Bailey Humber, Tariq Ahmed, Sri Mahavir Agarwal, Kristen Ward, Margaret Hahn
Metabolites.2024; 14(9): 475. CrossRef Unveiling the gut microbiota blueprint of schizophrenia: a multilevel omics approach
DongDong Qi, Peng Liu, YiMeng Wang, XuGuang Tai, ShiFa Ma
Frontiers in Psychiatry.2024;[Epub] CrossRef
|